16th & 17th NovemberManchester, UK

Innovation Sponsor

Online Market Place for R&D Outsourcing

Description: By enabling scientists to easily Outsource Everything but the Genius®, we are pioneering a faster, leaner and more innovation-centric approach to research. Our vision is to create a world in which scientists are limited only by their imagination.

Welcome

...to Biotech Outsourcing Strategies Manchester 2022

Launched in 2006 by Bio2Business Ltd, the Biotech Outsourcing Strategies Events bring together stakeholders in R&D outsourcing to share experience, build existing outsourcing partnerships and forge new buyer/supplier business relationships. The established BOS Formula is built on 4 key pillars; Exhibition showcasing international CROs and CMOs; High Quality Content (delivered through the multi-stream programme); 1-to-1 Partnering; Informal Networking (BOS Events are known for being friendly, intimate events, which create the perfect conditions for networking!).

We are delighted to bring the BOS Events to the north of England and to a city synonymous with industrial and technological progression. BOS Manchester 2022 will cover Discovery Outsourcing, Small Molecule CMC Outsourcing and Biologics CMC Outsourcing. We look forward to welcoming you to the events new home in the heart of Manchester.

Resources for Sponsors & Attendees

Our valued sponsors can access our Getting started with your BOS Manchester Sponsorship - Step-by-step Guide. In addition, sponsors can refer to a summary of the Exhibition Logistics. Book your accommodation at BOS Manchester 2022 by clicking here.

Covid restrictions were lifted in the United Kingdom in early 2022.

Featured Speaker (BOS Manchester 2022)

Designing a Robust Manufacturing Strategy for Personalised Vaccines

Dr Patrick Merky, Senior CMC Project Manager, Nykode Therapeutics

ABSTRACT: Nykode Therapeutics is developing a personalised neoantigen plasmid DNA cancer vaccine for treatment of patients with cancers of high unmet medical need. The manufacturing process from assessment of the patient’s tumour biopsy to the delivery of the respective drug requires a carefully orchestrated supply chain. The turnaround time is of vital importance as the patient is awaiting treatment with the vaccine to be manufactured. The platform based Good Manufacturing Practice (GMP) manufacturing process should be robust and streamlined to allow delivery of a batch size covering a full treatment... Click here to Read More

Featured Company (BOS Manchester 2022)

SEQENS
Seqens is a global leader in small molecules CDMO, with 60+ years expertise in developing and supplying small molecules APIs, intermediates (RSMs & GMP), and excipients (polymers and lipids).

Our network of cGMP and pre-GMP facilities in Europe and the US and CMC competencies allows our clients full...
View profile